This browser is no longer supported.
To provide you with the best possible experience, we kindly ask you to switch to a supported browser:
Are you a Healthcare Professional? Visit our Healthcare Professional Site
For Members of the Public in Ireland
Information on GSK medicines
Report a suspected side effect
umeclidinium/vilanterol inhalation powder
Patient information leaflet
This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
To report an adverse event or any other general enquiry.
© 2001-2020 GlaxoSmithKline plc. All rights reserved. Registered in Ireland: GlaxoSmithKline (Ireland) Limited, a private company limited by shares, and a member of the GlaxoSmithKline group of companies. Registered in Ireland with Company Number 15513. Registered office: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland. GOL. Last updated: March 2020 NP-IE-NA-WCNT-200001
This browser is not supported and will result in the website not being optimally presented. You are recommended to use an alternate browser such as Chrome, Opera or FireFox